Skip navigation

Refine by Type

Results 1 - 10 of 36 for bortezomib
  1. Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow) ... been treated with at least one other medication. Bortezomib is also used to treat people with mantle ...
  2. Myeloma (Leukemia & Lymphoma Society) - PDF  
    ... other drugs, including carfilzomib is under clinical investigation. Bortezomib (Velcade®). This drug, given intravenously (IV) or subcutaneously ( ... Treatments with novel agents include { { The proteasome inhibitor bortezomib (Velcade), plus liposomal doxorubicin (Doxil®) { { Velcade as a ...
  3. Myeloma Bone Disease: Current and Future Treatment (Bone and Cancer Foundation) - PDF  
    ... bone disease have identified several additional potential drugs. Bortezomib (Velcade®): Bortezomib (Velcade®), a drug used to treat myeloma, appears ... disease. Several studies have reported that patients on bortezomib have increased markers of bone formation in their ...
  4. ... the immune system) who have been treated with bortezomib (Velcade) and at least one other medication. Lenalidomide ...
  5. ... least two other medications, including lenalidomide (Revlimid) and bortezomib (Velcade). Pomalidomide is in a class of medications ...
  6. ... of renal disease in multiple myeloma Related Searches Bortezomib Lenalidomide Melphalan Melphalan prednisone thalidomide Multiple myeloma Patient ... Newer drugs such as thalidomide (Thalomid), lenalidomide (Revlimid), bortezomib ... carfilzomib (Kyprolis), and pomalidomide (Pomalyst) Corticosteroids such ...
  7. ... with this combination.Talk with your health provider.Bortezomib (Velcade)Bortezomib (Velcade) is used in certain types of cancers. Green tea might interact with bortezomib (Velcade) and decrease its effectiveness for treating certain ...
  8. ... least two prior therapies, including lenalidomide (Revlimid ® ) and bortezomib (Velcade ® ), and whose disease progressed within 60 days ... trial ( CC-4047-MM-007 ) is comparing pomalidomide, bortezomib, and low-dose dexamethasone with bortezomib plus low- ...
  9. Facts 2013 (Leukemia & Lymphoma Society) - PDF  
    ... brentuximab vedotin (Adcetris®); and proteasome inhibitors such as bortezomib (Velcade®) and carfilzomib (Kyprolis®). More than 50 individual ... with rituximab (Rituxan ® ) or a rituximab-containing regimen. Bortezomib (Velcade ® ) is indicated to treat people with myeloma. ...
  10. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... induce cancer cells to undergo apoptosis (cell death). Bortezomib (Velcade®) is approved to treat some patients with ... myeloma and some patients with mantle cell lymphoma . Bortezomib causes cancer cells to die by interfering with ...
previous · 1 · 2 · 3 · 4 · next